IQVIA Unveils AI Agents at GTC Paris to Enhance Workflows and Accelerate Insights for Life Sciences

Strategic Insights -

IQVIA, a leading global provider of clinical research services, commercial insights, and healthcare intelligence, has unveiled AI agents at GTC Paris, leveraging NVIDIA technology. These custom-built AI agents are designed to enhance workflows and accelerate insights for the life sciences industry. The collaboration with NVIDIA represents a pivotal opportunity to deliver precise and efficient workflows, backed by deep industry expertise and powerful technology partnerships.

Key Takeaways:

  • IQVIA's AI agents are custom-built using NVIDIA technology to enhance workflows and accelerate insights for the life sciences industry.
  • The AI agents are designed to simplify operations across life sciences, including target identification, clinical data review, literature review, market assessment, and HCP engagement.
  • IQVIA has announced a strategic collaboration with NVIDIA to build custom foundation models and agentic AI workflows to accelerate research, clinical development, and access to new treatments.
  • The collaboration aims to leverage AI applications trained on IQVIA's vast healthcare-specific information to enhance, streamline, and focus clinical trials and commercial launches with powerful workflow coordination and insights.
  • The use cases for these agentic offerings include target identification, clinical data review, literature review, market assessment, and HCP engagement.
  • IQVIA's thousands of customers are expected to benefit from this collaboration, with the potential to accelerate research and clinical development.

Statistics:

  • IQVIA has announced a strategic collaboration with NVIDIA to build custom foundation models and agentic AI workflows.
  • The collaboration aims to accelerate research, clinical development, and access to new treatments.
  • IQVIA's AI agents are expected to simplify operations across life sciences, including target identification, clinical data review, literature review, market assessment, and HCP engagement.
  • The use cases for these agentic offerings include target identification, clinical data review, literature review, market assessment, and HCP engagement.
  • IQVIA has approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology, and operational excellence.

Sources:

  • Businesswire.com, "IQVIA Unveils AI Agents at GTC Paris to Accelerate Insights for Life Sciences" (May 11, 2025)
  • Businesswire.com, "IQVIA Announces Strategic Collaboration with NVIDIA to Accelerate Research, Clinical Development, and Access to New Treatments" (January, 2025)
  • IQVIA Website, "About IQVIA" (2025)
  • NVIDIA Website, "About NVIDIA" (2025)